OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

Giants of Cancer Care

OncLive Community

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

OncLive TV: Zahi Mitri, MD

<< Back to Our Featured Experts

Dr. Mitri Discusses the Promise of Trastuzumab Biosimilars

Dr. Mitri Discusses the Promise of Trastuzumab Biosimilars

Dr. Mitri Discusses Adjuvant Therapy for HER2+ Breast Cancer

Dr. Mitri Discusses Adjuvant Therapy for HER2+ Breast Cancer

Dr. Mitri on Impact of Trastuzumab Biosimilar FDA Approval

Dr. Mitri on Impact of Trastuzumab Biosimilar FDA Approval

Oncology Specialists

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Jennifer Eads, MD

Paul Eber, MD

Paul R. Eber, MD

S. Gail Eckhardt, MD

Scott Eggener, MD

Alexander M. M. Eggermont, MD, PhD

Lawrence H. Einhorn, MD

David J. Einstein, MD

Wafik El-Deiry, MD, PhD, FACP

Areej R. El-Jawahri, MD

Anthony B. El-Khoueiry, MD

Bassel El-Rayes, MD

Ezzat Elhassadi, MD

Anthony D. Elias, MD

Matthew J. Ellis, MD, PhD

Renee Ellmers

Mark Emberton, MD

Mark Emberton, MD, FRCS

Stephen G Emerson, MD, PhD

Cathy Eng, MD

Cathy Eng, MD, FACP, FASCO

Elissa Engel, MD

Diana P. English, MD

Narendranath Epperla, MBBS, MS

Herbert A. Eradat, MD

Harry Erba, MD, PhD

Loretta Erhunmwunsee, MD

Marc Ernstoff, MD

Bernard J. Escudier, MD

Ramez N. Eskander, MD

Christian Winther Eskelund, MD

Kathleen Essel, MD

Kathleen G. Essel, MD

Laura Esserman, MD

Laura Esserman, MD, MBA

Laura J. Esserman, MD, MBA

Francisco J. Esteva, MD, PhD

Elihu H. Estey, MD

David M. Euhus, MD

Terry L. Evans, MD

Tracey Evans, MD

Tracey L. Evans, MD

William Eward, MD, DVM

Michael S. Ewer, MD, MPH, JD, LLM, MBA

Toby Eyre, MBChB, MRCP

Toby Eyre, MCBhB, MRCP

OncLive SAP

OncLive News Network On Location: ASH 2019 Day 3

Trending Now

Neoadjuvant Olaparib Combo Safe in Breast Cancer

Residual Cancer Burden Predicts Patient Outcomes Across Breast Cancer Subtypes

ctDNA and CTCs Potentially Poised to Predict Recurrence for Early TNBC

Estrogen Decreases Breast Cancer Incidence in Postmenopausal Women, Estrogen Plus Progestin Has Opposite Effect

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Priority Report

Dermatologists in Cancer Care®

Pulmonologists in Cancer Care

Rapid Reporter®

Milestones In Medicine

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2019
Intellisphere, LLC. All Rights Reserved.

x